Background The global burden of non-alcoholic fatty liver disease (NAFLD) parallels the
increase in obesity rates across the world. Although overweight and obesity status are …

Tissue stiffness has long been known to be a biomarker of tissue pathology. Ultrasound
elastography measures tissue mechanical properties by monitoring the response of tissue to …

We present here the first update of the 2013 EFSUMB (European Federation of Societies for
Ultrasound in Medicine and Biology) Guidelines and Recommendations on the clinical use …

These updated guidelines on the management of abnormal liver blood tests have been
commissioned by the Clinical Services and Standards Committee (CSSC) of the British …

Background & Aims Noninvasive methods have been evaluated for the assessment of liver
fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD). We …

The clinical part of these Guidelines and Recommendations produced under the auspices of
the European Federation of Societies for Ultrasound in Medicine and Biology EFSUMB …

In patients with compensated advanced chronic liver disease (cACLD), the presence of
clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears …

Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide. Currently, the routinely used modalities are unable to adequately determine the …

Aims This meta‐analysis aims to compare the diagnostic performance of acoustic radiation
force impulse (ARFI) elastography and transient elastography (TE) in the assessment of liver …